% 4% B f ace Ro l,es Corning Hazleton Inc.

AR R26 - 0764 ACTIVATED SLUDGE RESPIRATION INHIBITION TEST TEST SUBSTANCE Identity: MreifxetrurreedctoonatasiPniFnOgSp,erFfCl-u9o5r,ooocrtaansesaulcfoomnaptoen,ewnhtiocfhFmCa-y20a3lsCoF-bXe or FC-203CF. (1-Octanesulfonic acid) (CAS # 2795-39-3).

o Safety &n Health Research Laboratories SPONSOR Avenue E. vAanPNMiEewenhuyse, 4 B-11B60OXBru3ssels Belgium AR226-1803 AMMONIUM PERTFELSUTORITOEOMCTANOATE (APFO) EARLY-LIFE STAGE TSOXTIUCDIYTTYITTELEST IN RAINBOW TROUT UNDER FLOW-THROUGH CONDITIONS DATA REQUIREMENT OECD Guideline No. 210, 17th July 1992 STJUacDqYueDsIL'RHEarCidToOn R [EXPERIMENTAL COMPLETIONDATE 7 August 2003 DCAaTE lOFyISS2U0E k TEST FcArCILITY BP 563 -27005 Evreus - France LABORATORY 226S39TEUCDPY NUMBER Page 10f 112, 1SSNMCmRaeCcTohaprnche 4a40?

AR226-3044 Study Title Skin Irritation Test with H-21951 in Rabbits Laboratory Project ID Haskell Laboratory Report No. 782-96 Author Tracy A.

A Convention on Long-Range Transboundary Air Pollution p P1 age I of I R .2 2 6 _ 3 61 7 ~ UNEC E United Economic Commission. for Europe SEARCH ' , Convention News Histo ry of the Conventio Convention on Long-range Transbounda ry Air Pollution Protocol on Persistent Organic Pollutar nProtcls (POPS ) Organizational Cha rt Executive Body EMEP Steering Body The 1998 Aarhus Protocol on Persistent Organic Pollutants (POPs) Working Group on Effects Working Group o The Executive Bod y adopted the Protocol on Persistent Organic Review and nStraegis CAPACT Publications Pollutants on 24 June 1998 in Aarhus (Denmark) .

PFOS: ARX.

, 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Protocol for Study No.

At-,a titI;n;:'_-, 65 14q,Llscvi4s:cricncePuhii%hcrBs.%'.All i BBALIP -;.OIl The mechanism underlyingthe hypolipemic effect of perfluorooctanoiaccid(PFOA), perfluorooctanesulphonic acid(PFO.SA) and clofibriaccid Bente Haughom and OysteinSpydevold Iristiruorfei4edicalBiochemistrv,Universi@o%f- Oslo,Oslo (Nor.

OCTANOL/WATER PARTITION COEFFICIENT TEST SUBSTANCE Identity:N-ethylperfluorooctasnuelfonamidoethanolm;ay alsobe referredto as N-ETFOSE Alcoholor FM-3422.

ACUTE TOXICITY TO AQUATIC INVERTEBRATES TEST SUBSTANCE (DAPHNIA MAGNA) Identity:A mixturecontainingperfluorooctanesulfonatmea;y also be referredto as PFOS, FC-95, or as a component of FC-206CF or FC-206CF-X. (1-Octanesulfoniacid)(CAS # 2795-39-3).

AR26- 0496 BIOCONCENTRATION ITEESTSSUUBSTANNCCEE 000000000 Identity: PPeFrOflAuoarmoomcotnaniouimc ascailtd,,Aammmmoonniiuumm psaelrtf;lmuacryoaolcstaoncbaeter,efPeFrrOe,d FtoC-as 116, FC-126, + ammonium FC-169, or salt, CAS# 3F8C2-51-4236.-1()Octanoic acid, pentadecafiuoro- Remarks: The test sample is FC-143.

Co`CAS Number 2991-51-7 3M Company AR2260578 1 Voluntary Use and Exposure Information Profile Perfluorooctane sulfonamido ethyl acetate L CHEMICAL IDENTIFICATION Chemical Name: ~~ Perfluorooctane sulfonamido ethyl acetate (PFOSSA) `CAS Number: 2991-51-7 I.

g6HQ -0800.373 LG3INAL [p1%6--037>3 PHYSICALICHEMICAL PROPERTIES a. s \NAL 5=8 on TESi T SUBSTANCE > 3 Identity:[2r-e(fNe-rrEetdhytlopaesrfBl1u2o2r8o,ocDt-a1n,esuElIfFoOnSaEmiAd,o)oretFhXy-l1a3c.ry(l2a-tPer;ompaenyoiaclsaocibd&, 2- 4) [ethyllheptadecafluorooctysulfonyljaminolethyl ester, CAS # 423-82- 5) Remarks: Material is an amber solid. 0 Lo LR Remarks: Report states that sample purity is 99% or more based on information supplied by Sponsor.

BACK TO MAIN MULTI-CITY STUDY FIELD REPORT FOR CLEVELAND TENNESSEE AND DECATUR ALABAMA - BATTELLE DUXBURY ACTIVITIES for Project Number N100672-0 1 submitted to July 9,1999 Prepared by Scott C.

Al226-/548 Toxicological Summary Pros Dietary Acute Northern Bobwhite Study `Test Substance: Perfluorooctanesulfonate (PFOS) Structure: Remarks: METHODS poaium sah CASH 2795.335 |-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8.8,8-heptadecafluoro-, Trhedtesutndsuebrsatamnbceitis caownhdiitoenspoawndderur(GM wlats#o2r1g7i)nallTyhedrsammpilnedwa1s pleas be 90.49% byutp LCMS, 'H-HMR, riploiglon ""F-NMR and elemental analyses dCeotnecremninaeidontso ibnehi8s6s.u9%m.marTyhaersnvoamsienaolnatned 8m5e3as%urpeudrtydiveatatrey PFOS vTahleueis nbafsedphoanseherep0o.rt40wa%spourrgtiynaelsltyractoimopnletTeheinre2po0r0t0,waasndrrieepodrted 3008 to rflt the subsent revision. in ample purty This Toxicological Summary reflects these changes as well as including results from all of the associated reports of analyses of tissues collected during the in-life phase.